M3 Global Research Expands Qualitative Research Department- Next Important Step in M3 Group Growth Strategy

Key leadership changes announced for M3 Global Research, part of M3 Group that digitally reaches over 2.5 million physicians worldwide… and growing.

  • Share on TwitterShare on FacebookShare on Google+Share on LinkedInEmail a friend

Washington, DC (PRWEB) December 05, 2013

M3 Global Research, (http://research.m3.com), a market leader with the world’s largest verified healthcare professional panel, today announced two important leadership changes to help accelerate the company’s global growth: the appointment of Alan Mavretish as Vice President of Market Research and the promotion of Brooke Allen-Watson to US Qualitative Manager.

Mr. Mavretish previously worked at online Qualitative platform pioneer iTracks and Baxter Healthcare, and has nearly 20 years of qualitative research experience. He earned a degree in Business Administration from Duquesne University and will be based in Pennsylvania. Ms. Allen-Watson has 7 years of qualitative experience and previously worked for Focus Pointe Global and FocusForward.

Last week M3 announced the doubling of its digital US physician reach through an exclusive agreement with PDR, (http://mdlinx.pdr.net), one of the most trusted names by physicians. M3 now reaches over 2.5 million physicians worldwide digitally and has a healthcare professional reach that exceeds 4 million when including nurses, dentists, physician assistants, lab managers, payers, and pharmacists.

“M3 has quickly grown to be a market leader in Qualitative Healthcare Research around the world adding capabilities in the US and Japan this year which complement our market leading EU capabilities which feature a London based call center and studios in Hammersmith,” said Bill Friedrich Director of Market Research Services.

M3 Global Research is the only healthcare panel in the world ISO certified to the market research standard ISO26362. “2013 has been a pivotal year for M3 Global Research to expand global panel coverage and attract top notch talent to keep our expanding client base serviced with the highest quality healthcare data collection service,” said Roni DasGupta who heads up the M3 Global Research business development teams in the US and EU, “M3’s focus for 2013 has been on the 3 Q’s of Quality, Quantitative, and Qualitative healthcare research.”

About M3 Group
The M3 Group operates in the US, Asia, and Europe with over 2.5 million physician members globally via its physician websites such as http://www.m3.com, http://www.mdlinx.com, research.m3.com, http://www.doctors.net.uk and http://www.medigate.net. M3 Inc. is a publicly traded company on the Tokyo Stock Exchange (jp:2413) with subsidiaries in major markets including USA, UK, Japan, S. Korea, and China. M3 Group provides services to healthcare and the life science industry. In addition to market research, these services include medical education, ethical drug promotion, clinical development, job recruitment, and clinic appointment services. M3 has offices in Tokyo, Washington D.C., Fort Washington, PA, Oxford, London, and Seoul.

M3 Group Sites
mdlinx.com | networksinhealth.com | thesmartestdoc.com | research.m3.com | mdlinx.pdr.net


Contact